Drug Rash with Eosinophilia and Systemic Symptoms Syndrome in a Patient on Sulfasalazine for Ulcerative Colitis

다국어 초록 (Multilingual Abstract)

Drug rash with eosinophilia and systemic symptoms (DRESS) is a life-threatening systemic drug reaction characterized by fever, rash, hematological abnormalities, lymphadenopathy, and multiple internal organ involvement. Unfortunately, a long latency period as well as clinicians' unawareness of the disease entity often results in a delay of prompt diagnosis and treatment in clinical practice. A search of the literature revealed only few reports on DRESS in patients with inflammatory bowel diseases. The pathogenesis of the disease is not clearly understood, although several possible mechanisms, such as drug detoxification, slow acetylation, and reactivation of human herpes viruses, have been proposed in its development. Here, we present a rare case of DRESS associated with viral reactivation and defects in drug metabolism in a 22-year-old man who had been on sulfasalazine for 6 weeks to treat ulcerative colitis.

참고문헌 (Reference)

1 Peyrière H, "Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?" 155 : 422-428, 2006

2 Kardaun SH, "Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?" 156 : 609-611, 2007

3 Kano Y, "The variable clinical picture of drug-induced hypersensitivity syndrome/drug rash with eosinophilia and systemic symptoms in relation to the eliciting drug" 29 : 481-501, 2009

4 Shiohara T, "The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations" 156 : 1083-1084, 2007

5 Watkinson G, "Sulphasalazine: a review of 40 years’ experience" 32 (32): 1-11, 1986

6 Amos RS, "Sulphasalazine for rheumatoid arthritis: toxicity in 774 patients monitored for one to 11 years" 293 : 420-423, 1986

7 Aquino RT, "Sulfasalazine- induced DRESS syndrome (Drug Rash with Eosinophilia and Systemic Symptoms)" 126 : 225-226, 2008

8 Rieder MJ, "Prominence of slow acetylator phenotype among patients with sulfonamide hypersensitivity reactions" 49 : 13-17, 1991

9 Tohyama M, "New aspects of drug-induced hypersensitivity syndrome" 38 : 222-228, 2011

10 Miura H, "Drug-induced hypersensitivity syndrome associated with reactivation of human herpesvirus 6 presenting with severe hepatic injury" 1 : 127-132, 2008

11 Descamps V, "Drug-induced hypersensitivity syndrome associated with Epstein-Barr virus infection" 148 : 1032-1034, 2003

12 Walsh SA, "Drug reaction with eosinophilia and systemic symptoms (DRESS): a clinical update and review of current thinking" 36 : 6-11, 2011

13 Rosenbaum J, "Drug rash with eosinophilia and systemic symptoms secondary to sulfasalazine" 46 : 193-196, 2010

14 Michel F, "DRESS syndrome in a patient on sulfasalazine for rheumatoid arthritis" 72 : 82-85, 2005

15 Tamagawa-Mineoka R, "DRESS syndrome caused by teicoplanin and vancomycin, associated with reactivation of human herpesvirus- 6" 46 : 654-655, 2007

16 Um SJ, "Clinical features of drug-induced hypersensitivity syndrome in 38 patients" 20 : 556-562, 2010

17 Boccara O, "Association of hypogammaglobulinemia with DRESS (Drug Rash with Eosinophilia and Systemic Symptoms)" 16 : 666-668, 2006

18 Descamps V, "Association of human herpesvirus 6 infection with drug reaction with eosinophilia and systemic symptoms" 137 : 301-304, 2001

19 Kano Y, "Association between anticonvulsant hypersensitivity syndrome and human herpesvirus 6 reactivation and hypogammaglobulinemia" 140 : 183-188, 2004

20 Aihara M, "Anticonvulsant hypersensitivity syndrome associated with reactivation of cytomegalovirus" 144 : 1231-1234, 2001